Change search
ReferencesLink to record
Permanent link

Direct link
Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study.
Show others and affiliations
2005 (English)In: J Am Coll Cardiol, ISSN 0735-1097, Vol. 45, no 5, 712-9 p.Article in journal (Refereed) Published
Place, publisher, year, edition, pages
2005. Vol. 45, no 5, 712-9 p.
Keyword [en]
Adrenergic beta-Antagonists/*therapeutic use, Aged, Aged; 80 and over, Angiotensin II Type 1 Receptor Blockers/*therapeutic use, Atenolol/*therapeutic use, Atrial Fibrillation/*drug therapy/mortality, Cause of Death, Double-Blind Method, Female, Humans, Hypertension/*drug therapy/mortality, Hypertrophy; Left Ventricular/*drug therapy/mortality, Losartan/*therapeutic use, Male, Middle Aged, Prospective Studies, Recurrence/prevention & control, Risk Factors, Stroke/*drug therapy/mortality, Survival Rate
URN: urn:nbn:se:umu:diva-6291DOI: doi:10.1016/j.jacc.2004.10.068PubMedID: 15734615OAI: diva2:145960
Available from: 2007-12-08 Created: 2007-12-08 Last updated: 2011-01-12Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Lindholm, Lars H
By organisation
Family Medicine

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 13 hits
ReferencesLink to record
Permanent link

Direct link